European Archives - Page 890 of 1232 - European Medical Journal

ESC 2018 - Congress Highlights

Join us and catch a brief glimpse into the venue of this year’s European Society of Cardiology (ESC) annual congress, in our inside look at Messe München…

The Importance of Individualised Fertility Care: An Interview with Dr Elena Labarta, Gynaecologist, IVI Clinic Valencia

The field of reproductive health is currently seeing rapid advancements. This was very much on display at the recent European Society of Human…

Important Discovery of Long-Living Macrophages in the Gastrointestinal Tract

Long-living macrophages in the gastrointestinal system play a crucial role in ensuring that the intestine functions normally in mice, researchers from…

Rare Cancer Continues to Take Lives

The number of lives lost due to cancer each year is astronomical. According to the World Health Organization (WHO): “Cancer is the second leading cause…

Short Telomeres in Heart Muscle Cells is a Feature of Cardiomyopathy

Abnormally short telomeres in the heart muscle cells (cardiomyocytes) of cardiomyopathy patients have been found by researchers from Stanford…

European Medical Journal Presents: EMJ 3.3

Presenting high-quality peer-reviewed articles that are sure to whet the appetite of individuals from across the field of medicine, EMJ 3.3 details…

Editor’s Pick: Chimeric Antigen Receptor-Engineered T Cell Therapy in Acute Myeloid Leukaemia

Acute myeloid leukaemia (AML) is a disease with a very poor outcome and remains an area of significant unmet need, necessitating novel therapeutic…

European Medical Journal 3.3 2018

Hello and welcome. It is my great pleasure to introduce to you the third edition of the European Medical Journal for 2018: EMJ 3.3. As always, our…

Adherence During Early Allergen Immunotherapy and Strategies to Motivate and Support Patients

Allergic rhinitis is one of the most common chronic inflammatory conditions, affecting up to 30% of people in Europe. Allergen immunotherapy (AIT)…

Interim Results of the Basket of Real-World Randomised Clinical PRISM Trials for M’Sure-S, a Next-Generation Sirolimus-Eluting Stent, Versus Eliminator, an Everolimus-Eluting Stent

This study compared sirolimus-eluting stents (SES) with everolimus-eluting stents (EES) in coronary artery disease patients.